Journals / Erciyes Tıp Dergisi / 2010 / Cilt: 32 - Sayı: 3

Dexmedetomidine-fentanyl combination in awake craniotomy

Uyanık kraniyotomide deksmedetomidin- fentanil kombinasyonu

Pages
217–220
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Dexmedetomidine-fentanyl combination was well tolerated in this adolescent patient and provided good surgical conditions and patient comfort during tumor resection and testing.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Awake craniotomy is a common procedure in resection of lesions near critical functional regions, particularly the speech and motor areas.
📊
Key Findings & Data:During awake craniotomy, patients need to be fully alert and cooperative during testing.
💡
Conclusion & Impact:Dexmedetomidine-fentanyl combination was well tolerated in this adolescent patient and provided good surgical conditions and patient comfort during tumor resection and testing.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Awake craniotomy is a common procedure in resection of lesions near critical functional regions, particularly the speech and motor areas. During awake craniotomy, patients need to be fully alert and cooperative during testing. On the other hand, it is desirable to keep them sedated, avoiding discomfort, anxiety and pain over the rest of the surgery. In this case report, we report our successful use of dexmedetomidine-fentanyl combination for sedation in intracranial tumor resection with awake craniotomy. Dexmedetomidine-fentanyl combination was well tolerated in this adolescent patient and provided good surgical conditions and patient comfort during tumor resection and testing.

Özet

Uyanık kraniyotomi; beynin kritik fonksiyona sahip bölgelerinde, özellikle konuşma ve motor alanına yakın bölgelerde uygulanması yaygınlaşan bir uygulamadır. Uyanık kraniyotomi, hastanın testlerin yapılması sırasında tam uyanık ve koopere olmasını, cerrahinin geri kalan döneminde ise sedatize olmasını, rahatsızlık, anksiyete ve ağrı hissetmemesini gerektirir. Bu yazıda, uyanık kraniyotomi ile intrakraniyal tümör rezeksiyonu için başarıyla uyguladığımız deksmedetomidin-fentail kombinasyonu sedasyonunu sunuyoruz. Deksmedetomidin-fentanil kombinasyonu bu adolesan hasta tarafından iyi tolere edilmiş ve tümör rezeksiyonu ve testlerin uygulanımı sırasında iyi hasta komforu ve cerrahi ortam sağlamıştır.

🔖

Cite This Article

AKSU, R., BİÇER, C., MADENOĞLU, H., BOZOĞLUER, E., AKDEMİR, C., BOYACI, A. (2022). Dexmedetomidine-fentanyl combination in awake craniotomy. Erciyes Tıp Dergisi, Cilt: 32 - Sayı: 3, 217–220. https://ajindex.com/articles/502546

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Rozet I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol 2008; 21(5): 537-543
  2. Berkenstadt H, Perel A, Hadani M, Unofrievich I, Ram Z. Monitored anesthesia care using remifentanil and propofol for awake craniotomy. J Neurosurg Anesthesiol 2001; 13: 246-249
  3. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-268
  4. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-394
  5. Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 2004; 16: 20-25
  6. Sinha PK, Koshy T, Gayatri P, et al. Anesthesia for awake craniotomy: a retrospective study. Neurol India 2007; 55: 376-381
  7. Herrick IA, Craen RA, Gelb AW, et al. Propofol sedation during awake craniotomy for seizure s: electrocorticographic and epileptogenic effects. Anesth Analg 1997; 84: 1280-1284
  8. Manninen PH, Balki M, Lukitto K, Bernstein M. Patient satisfaction with awake craniotomy for tumor surgery: a comparison of remifentanil and fentanyl in conjunction with propofol. Anesth Analg 2006; 102: 237-242
  9. Kamibayashi T,ÊMaze M. Clinical uses of alpha2 - adrenergic agonists. Anesthesiology.Ê2000; 93:1345- 1349
  10. Moore TA 2nd, Markert JM, Knowlton RC. Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection. Anesth Analg. 2006; 102:1556-1558
  11. Everett LL, Van Rooyen I, Warner MH, Shurtleff HA, Saneto RP, Ojemann JG. Use of dexmedetomidine in awake craniotomy in adolescents: report of two cases. Pediatr Anesth 2006;16:338-342
  12. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL.The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993; 78:813-820
  13. Ard JL Jr, Bekker AY, Doyle WK. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol 2005;63:114-116
  14. Sloan TB. Anesthetic effects on electrophysiologic recordings. J Clin Neurophysiol. 1998;15:217-226
  15. McGuire G, El-Beheiry H, Manninen P, Lozano A, Wennberg. R. Activation of electrocorticographic activity with remifentanil and alfentanil during neurosurgical excision of epileptogenic focus. Br J Anaesth 2003; 91: 651–665
  16. Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA. Dexmedetomidine and neurocognitive testing in